Retinopathy Of Prematurity

SEATTLE —There was no significant difference in cognitive outcomes for patients with retinopathy of prematurity treated with intravitreal bevacizumab compared with those treated with laser photocoagulation, according to a speaker here.

Prenatal maternal factors such as socioeconomic status, smoking and chorioamnionitis were found in a study to be associated with the risk for retinopathy of prematurity in preterm infants.

The FDA approved Eylea for the treatment of retinopathy of prematurity in preterm infants, according to a press release from Regeneron.

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2023, Yoshihiro Yonekawa, MD, discusses nomenclature updates for retinopathy of prematurity and retinal surgery in pediatric patients.

KOLOA, Hawaii — Socioeconomic factors have led to disparities in access to retinopathy of prematurity care, according to a speaker at Retina 2023.

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, R.V. Paul Chan, MD, discusses treatment options for pediatric retinal disease and retinopathy of prematurity.

NEW YORK — A survey distributed to pediatric ophthalmology and retina fellows at a number of U.S. universities investigated current trends in retinopathy of prematurity training and practice.

NEW YORK — The incidence of retinopathy of prematurity among at-risk infants has almost doubled during the past 2 decades and is greater in historically marginalized groups, according to a poster presented here.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, Darius M. Moshfeghi, MD, discusses research into the math of ROP, in which he believes size of the eye may affect the amount of treatment needed.

WAIKOLOA, Hawaii — Systemic effects of anti-VEGF in retinopathy of prematurity have not been ruled out, so it may be wise to use bevacizumab in lower doses or switch to agents with less systemic exposure, according to one presenter.